Insilico on Applying AI to Transform Drug Discovery
Bloomberg Tech
•
Generative AI
Insilico Medicine Founder & CEO Alex Zhavoronko discusses how his company aims to apply artificial intelligence to revolutionize drug discovery and longevity research. He speaks with Haslinda Amin from the sidelines of 'JPMorgan Global China Summit' in Shanghai.